USPTO serial 78277322
ETHICA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 26, 2006
- Examiner
- ANKRAH, NAAKWAMA S
- Law office
- GENERIC WEB UPDATE
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ETHICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
KIRKLAND, QUEBEC, CA
Montreal, Quebec, CA
Dorval, Quebec, CA
Dorval, Quebec, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dan S. Cohn
Dan S. Cohn HUSCH BLACKWELL LLP190 Carondelet Plaza, Suite 600ST. LOUIS, MO 63105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Clinical trial supplies management services, namely-customized drug packaging and labeling, central and site administered randomization and study supply distribution; developing and managing distribution and storage logistics for all clinical supplies, namely study drugs and devices, case report forms, study binders and all study related documentation; clinical trial management services, namely-pre-study document collection and review, site selection, pre-study site visits, initiation visits, monitoring visits, close-out visits, project tracking and monitoring reports, negotiation and administration of investigator grants, labeling, packaging, distribution, coordination and tracking of clinical trial materials, regulatory document processing, central laboratory selection and coordination; managing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; managing the development of all study related documents and materials, namely study protocols, amendments, paper and electronic case report forms, and informed consent forms; managing study operations/monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters; management of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; managing all aspects of study drug reconciliation and inventory and distribution reports; managing all aspects of clinical trials, namely managing investigators, technicians, and participants, ethical reviews, investigator meetings, databases, statistical analyses and reporting, randomization logistics, medical writing services; recruitment of investigators, technicians and participants; providing strategies for recruitment of participants | ACTIVE | Sep 1, 2002 |
| 041 | Study specific clinical personnel training programs for investigators, coordinators and investigator meetings; conducting investigator meetings | ACTIVE | Sep 1, 2002 |
| 042 | Research services for clinical trials for others, namely conducting an ethical review of projects to protect the rights and welfare of research participants, developing study protocols, designing case report forms, developing participant screening tools, namely general and medical questionnaires, developing complete databases in accordance with strict guidelines, tracking of study parameters, providing statistical analyses, reporting and developing tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; developing and implementing randomization logistics, namely randomization envelopes, customized blind-breakable drug labeling, code break management and reports, manufacturing of subject-and protocol-specific kits using bulk oral and topical medications; medical writing services, namely-drafting clinical study protocols, amendments, case report forms, informed consent forms, statistical analysis plans, full integrated clinical research reports, publications, abstracts and manuscript; developing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; developing study operations and monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters | ACTIVE | Sep 1, 2002 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ETHICA CRO INC.
- Other trademarks owned by Ethica Clinical Research Inc.
- Other trademarks owned by Ethica Clinical Research Inc.
- Other trademarks owned by Ethica Clinical Research Inc.
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named ETHICA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 26, 2025 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Sep 20, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 23, 2017 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Feb 23, 2017 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Feb 23, 2017 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Feb 23, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 22, 2016 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Dec 26, 2015 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jan 16, 2013 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jan 15, 2013 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 15, 2013 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 20, 2012 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 23, 2009 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 23, 2009 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 29, 2007 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Dec 26, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 10, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 20, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 18, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 11, 2006 | ALIE | ASSIGNED TO LIE | — |
| Aug 1, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 12, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 13, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 15, 2006 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| May 15, 2006 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Feb 15, 2006 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Feb 15, 2006 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Dec 28, 2005 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Dec 28, 2005 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Dec 22, 2005 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Dec 21, 2005 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2005 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 13, 2005 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 20, 2005 | IUAA | USE AMENDMENT ACCEPTED | — |
| May 18, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Apr 29, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2005 | FAXX | FAX RECEIVED | — |
| Apr 11, 2005 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 11, 2005 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 10, 2005 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 9, 2004 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 9, 2004 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 12, 2004 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 12, 2004 | ALIE | ASSIGNED TO LIE | — |
| Aug 9, 2004 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 9, 2004 | ALIE | ASSIGNED TO LIE | — |
| Jul 30, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2004 | PAPER RECEIVED | — | |
| Jul 26, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 27, 2004 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 17, 2003 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Sep 10, 2003 | IUAF | USE AMENDMENT FILED | — |
| Sep 10, 2003 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |